Conjugated linoleic acid modulates phorbol ester-induced PPAR-δ and K-FABP mRNA expression in mouse skin

Nutrition Research

Volumn 27, Issue 1, 2007, Pages 48-55

  Belury, Martha A ^a   Kavanaugh, Claudine J ^b   Liu, Kai Li ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

12 O Tetradecanoylphorbol 13 acetate; Conjugated linoleic acid; Keratinocyte fatty acid binding protein; Mouse; Peroxisome proliferator activated receptors; Skin tumorigenesis

Indexed keywords

ACETONE; CONJUGATED LINOLEIC ACID; FATTY ACID BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONJUGATION; CONTROLLED STUDY; DIETARY INTAKE; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CELL; SKIN PAPILLOMA; SKIN TUMOR;

MUS;

EID: 33846595322     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.09.026     Document Type: Article

References (49)

1. Lavillonniére F., Martin J.C., Bougnoux P., and Sébédio J.L. Analysis of conjugated linoleic acid isomers and content in French cheeses. J Am Oil Chem Soc 75 (1998) 343-352
2. Yurawecz M.P., Roach J.A., Sehat N., Mossoba M.M., Kramer J.K., Fritsche J., et al. A new conjugated linoleic acid isomer, 7 trans, 9 cis-octadecadienoic acid, in cow milk, cheese, beef and human milk and adipose tissue. Lipids 33 (1998) 803-809
3. Belury M.A. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132 (2002) 2995-2998
4. Belury M.A., Nickel K.P., Bird C.E., and Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 26 (1996) 149-157
5. Liu K.L., and Belury M.A. Conjugated linoleic acid modulation of phorbol ester-induced events in murine keratinocytes. Lipids 32 (1997) 725-730
6. 2 production and hyperplasia in mouse epidermis. Nutr Cancer 33 (1999) 132-138
7. Cattley R.C., Elcombe C., Fenner-Crisp P., Lake B.G., Marsman D.S., Pastoor T.A., et al. Do peroxisome proliferation compounds pose a hepatocarcinogenic hazard to humans?. Regul Toxicol Pharmacol 27 (1998) 47-60
8. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
9. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270 (1995) 12953-12956
10. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligand of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11 (1997) 779-791
11. Belury M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Ann Rev Nutr 22 (2002) 505-531
12. Kliewer S.A., Umesono K., Noonan D.J., Heytman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and TNF-α suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of PPs signaling pathway through heterodimer formation of their receptors. Nature 358 (1992) 771-774
13. Aldridge T.C., Tugwood J.D., and Greens S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J 306 (1995) 437-479
14. Schoonjans K., Staels B., and Auwerx J. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302 (1996) 93-109
15. Peters J.M., Cattley R.C., and Gonzalez F.J. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator WY-14,643. Carcinogenesis 18 (1997) 2029-2033
16. Park B.H., Vogelstein B., and Kinzler K.W. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A 98 (2001) 2598-2603
17. Mueller E., Sarraf P., Tontonoz P., Evans R.M., Martin K.J., Zhang M., et al. Terminal differentiation of human breast cancer through PPARγ. Mol Cell 1 (1998) 465-470
18. Kubota T., Koshizuda K., Williamson E.A., Asou H., Said J.W., Holden S., et al. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58 (1998) 3344-3352
19. Jaeckel E.C., Raja S., Tan J., Das S.K., Dey S.K., Girod D.A., et al. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 127 (2001) 1253-1259
20. Tong B.J., Tan J., Tajeda L., Das S.K., Chapman J.A., DuBois R.N., et al. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2 (2000) 483-490
21. Demetri G.D., Fletcher C.D., Mueller E., Sarraf P., Naujoks R., Campbell N., et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci U S A 96 (1999) 3951-3965
22. Matsuura H., Adachi H., Smart R.C., Xu X., Arata J., and Jetten A.M. Correlation between expression of peroxisome proliferator-activated receptor β and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol 147 (1999) 85-92
23. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., and Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142 (2001) 4195-4202
24. Michalik L., Desvergne B., Basu-Modak S., Tan N.S., and Wahli W. Nuclear hormone receptors and mouse skin homeostasis: implication of PPAR beta. Horm Res 54 (2000) 263-268
25. Rivier M., Safonova I., Lebrum P., Griffiths C.E.M., Ailhaud G., and Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111 (1998) 1116-1121
26. Komuves L.G., Hanley K., Lefebvre A.M., Man M.Q., Ng D.C., Bikle D.D., et al. Stimulation of PPAR alpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 115 (2000) 353-360
27. Robisin N.A., LeCelle P.T., and Eckert R.L. Involucrin is a covalently cross-linked constituent of highly purified epidermal corneocytes: evidence for a common pattern of involucrin cross-linking in vivo and in vitro. J Invest Dermatol 107 (1996) 101-107
28. Thuillier P., Anchiraico G.J., Nickel K.P., Maldve R.E., Gimenez-Conti I., Muga S.J., et al. Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion. Mol Carcinog 29 (2000) 134-142
29. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15 (1995) 3012-3022
30. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) alpha and PPAR beta mutant mice. J Cell Biol 154 (2001) 799-814
31. Tan N.S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., et al. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15 (2001) 3263-3277
32. Di-Poi N., Tan N.S., Michalik L., Wahli W., and Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10 (2002) 721-733
33. Kim D.J., Akiyama T.E., Harman F.S., Burns A.M., Shan W., Ward J.M., et al. PPAR beta {(d)}-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem 279 (2004) 23719-23727
34. Belury M.A., Moya-Camarena S.Y., Sun H., Snyder E., Davis J.W., Cunningham M.L., et al. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver. Toxicol Appl Pharmacol 151 (1998) 254-261
35. Vanden Heuvel J.P., Clark G.C., Kohn M.C., Tritscher A.M., Greenlee W.F., Lucier G.W., et al. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res 54 (1994) 62-68
36. Belury M.A., Moya-Camarena S.Y., Liu K.L., Vanden J., and Heuvel P. Dietary conjugated linoleic acid induced peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J Nutr Biochem 8 (1997) 579-584
37. Hanley K., Jiang Y., Crumrine D., Bass N.M., Appel R., Elias P.M., et al. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100 (1997) 705-712
38. Peters J.M., Lee S.S., Li W., Ward J.M., Gavrilova O., Everett C., et al. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta). Mol Cell Biol 20 (2000) 5119-5128
39. Reiners Jr. J.J., and Slaga T.J. Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes. Cell 32 (1983) 247-255
40. Parkinson E.K. Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumor promotion by phorbol esters and by deep skin wounding. Br J Cancer 52 (1985) 479-493
41. Kane C.D., Coe N.R., Vanlandingham B., Krieg P., and Bernlohr D.A. Expression purification and ligand-binding analysis of recombinant keratinocyte lipid binding protein (mal-1), an intracellular lipid binding protein found overexpressed in neoplastic skin cells. Biochemistry 35 (1996) 2894-2900
42. Sweetser D.A., Heuckeroth R.O., and Gordon J.I. The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of function. Ann Rev Nutr 7 (1987) 337-359
43. Hotamisligil G.S., Johnson R.S., Distel R.J., Ellis R., Papaioannou V.E., and Spiegelman B.M. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 (1996) 1377-1379
44. Tan N.S., Shaw N.S., Vinckenbosch M., Liu P., Yasmin R., Desvergne B., et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22 (2002) 5114-5127
45. Krieg P., Feil S., Ürstenberger F.G., and Bowden G.T. Tumor-specific overexpression of a novel keratinocyte lipid-binding protein. Identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J Biol Chem 268 (1993) 17362-17369
46. Krieg P., Finch J., Üstenberger F.G., Melber K., Matrisian L.M., and Bowden G.T. Tumor promoters induce a transient expression of tumor-associated genes in both basal and differentiated cells of the mouse epidermis. Carcinogenesis 9 (1988) 95-100
47. Holladay K., Fujiki H., and Bowden G.T. Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes. Mol Carcinog 5 (1992) 6-24
48. Bernlohr D.A., Simpson M.A., Hertzel A.V., and Banaszak L.J. Intracellular lipid-binding proteins and their genes. Ann Rev Nutr 17 (1997) 277-303
49. Hertzel A.V., and Bernlohr D.A. Cloning and chromosomal location of the murine keratinocyte lipid-binding protein gene. Gene 221 (1998) 235-243